Fractal Analytics has reported a significant surge in its fourth-quarter financial performance, with net profit more than doubling to ₹115 crore. The enterprise AI firm saw its revenue from operations grow by 17% year-on-year to ₹886.3 crore during the March quarter, fueled by an intensifying global demand for artificial intelligence services and strategic margin expansion.
The results cap off a strong fiscal year 2026 for the company, which saw total annual revenue rise 19% to ₹3,300 crore. Net profit for the full year increased by 30% to ₹287 crore, though the company noted that excluding losses from associates, the annual profit rose more sharply by 43% to ₹357 crore, according to company filings available through Fractal’s official corporate channels.
This growth trajectory highlights a broader shift in the corporate landscape, where “frontier intelligence”—AI capable of planning, reasoning, and executing complex enterprise tasks—is becoming more accessible and affordable for large-scale deployment. The company’s ability to scale its profit faster than its revenue suggests a successful optimization of operational efficiencies and a high-value product mix.
Sector-Specific Growth: Healthcare and BFSI Lead the Charge
The most striking aspect of the Q4 results is the explosive growth within the Healthcare and Life Sciences vertical. This segment emerged as the company’s fastest-growing arm, posting a massive 82% year-on-year increase in the March quarter. For the full financial year, the vertical grew by 66%, signaling a deep integration of AI into clinical reasoning and diagnostic scenarios.
Similarly, the Banking, Financial Services, and Insurance (BFSI) sector showed robust momentum, growing 42% in the fourth quarter and 32% over the course of the full year. These figures underscore a trend where highly regulated industries are increasingly relying on AI to manage risk, automate compliance, and enhance customer experience.
Srikanth Velamakanni, Group CEO of Fractal Analytics, emphasized the evolving nature of the technology during the results announcement. “We wrapped up FY2026 on a strong note, with robust revenue and profit growth while delivering AI-led transformation for our clients,” Velamakanni stated. He added that AI is becoming more capable every day, particularly in its ability to “plan, reason, and act through complex enterprise work.”
Global Market Footprint and R&D Investment
Geographically, the United States remains the cornerstone of Fractal’s operations, contributing over 67% of the company’s total revenue and growing 20% during the year. However, the company is seeing accelerated adoption in other regions; Europe, specifically, grew by 24% in the fourth quarter and 34% across the full financial year.
To sustain this momentum, Fractal has maintained a disciplined approach to innovation. The company reported that research and development (R&D) spending accounted for 6.4% of its annual revenue. This investment has manifested in high-performing AI models that challenge global benchmarks.
Among these innovations is Vaidya.ai 2.0, a consumer-targeted AI health assistant. The model became the first AI to achieve a score of 50+ on OpenAI’s HealthBench (Hard), a rigorous benchmark for advanced clinical reasoning. The company’s PiEvolve—an evolutionary agentic engine for autonomous machine learning—has ranked among the top-performing agents on OpenAI’s MLE-Bench, outperforming agents from several leading global AI research labs.
Financial Performance Summary: FY26
| Metric | Q4 FY26 Performance | Full Year FY26 Performance |
|---|---|---|
| Revenue | ₹886.3 Crore (↑ 17% YoY) | ₹3,300 Crore (↑ 19% YoY) |
| Net Profit | ₹115 Crore (More than doubled) | ₹287 Crore (↑ 30% YoY) |
| Healthcare Growth | ↑ 82% YoY | ↑ 66% YoY |
| BFSI Growth | ↑ 42% YoY | ↑ 32% YoY |
| Europe Growth | ↑ 24% YoY | ↑ 34% YoY |
What This Means for the Enterprise AI Market
The financial health of Fractal Analytics serves as a bellwether for the enterprise AI sector. While much of the public discourse around AI focuses on consumer chatbots, the growth in “vertical AI”—specialized models for healthcare and finance—indicates that the real economic value is migrating toward industry-specific applications.
The company’s Net Revenue Retention of 114% (reported in previous quarters) and a Net Promoter Score (NPS) of 77 suggest high client satisfaction and a strong ability to expand existing accounts. The increase in high-value clients—those generating over $20 million in revenue—indicates that Fractal is successfully moving up-market to serve the world’s largest organizations.
The combination of high gross margins (which stood at 47.2% in Q3) and aggressive R&D spending suggests a strategy of “defensible innovation.” By building models that outperform general-purpose AI in specialized domains like clinical reasoning, Fractal is creating a competitive moat that is difficult for generalist AI providers to breach.
As the company moves into the next fiscal year, the focus is expected to remain on the deployment of agentic AI—systems that do not just provide answers but can autonomously execute workflows. This shift from “AI as a consultant” to “AI as an operator” is likely to be the primary driver of the next phase of revenue growth.
The next confirmed checkpoint for investors and analysts will be the release of the Q1 FY27 financial results, which will provide the first indication of whether the momentum in the Healthcare and European markets continues into the new fiscal cycle.
World Today Journal encourages readers to share their thoughts on the rise of vertical AI in the comments below.